| Dr Maneesha Priya Deo, PHARMD | |
|
250 Bon Air Rd, Greenbrae, CA 94904-1702 | |
| (510) 688-4342 | |
| Not Available |
| Full Name | Dr Maneesha Priya Deo |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 250 Bon Air Rd, Greenbrae, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336705540 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 78892 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maneesha Priya Deo, PHARMD Po Box 55733, Hayward, CA 94545-0733 Ph: () - | Dr Maneesha Priya Deo, PHARMD 250 Bon Air Rd, Greenbrae, CA 94904-1702 Ph: (510) 688-4342 |
News Archive
NEW drugs being developed for the treatment of prostate cancer may not be targeting the root cause of the disease, according to research published today (Friday, 24 January 2014) in Cell Death & Differentiation.
HealthCare Resolution Services, Inc., a leading provider of program integrity support, health information technology services and professional medical and technical staffing services, announced today that it has been awarded a contract with the U.S. Air Force's Commodities Council to support the Air Education and Training Command (AETC) with medical records coding and analysis, auditing, and provider training.
Angion Biomedica Corp., a biopharmaceutical company dedicated to the discovery and development of novel therapeutics that enhance quality of life, eradicate disease and save lives by modulating the body's protective, reparative and regenerative systems, announced today that its lead therapeutic BB3 was accepted into the Fast Track program of the U.S. Food and Drug Administration (FDA) and has also been designated an Orphan Drug product by FDA.
The ratio of women to men with the autoimmune disease systemic lupus erythematosus (SLE) is nine to one and the incidence increases after puberty.
Primary ciliary dyskinesia (PCD) is a rare, genetic respiratory tract disorder leading to progressive pulmonary dysfunction. It exhibits many problems typical for orphan diseases: delayed diagnosis, limited evidence-based knowledge etc. The European Union is funding BESTCILIA (Better Experimental Screening and Treatment for Primary Ciliary Dyskinesia) to introduce uniform guidelines for PCD treatment and diagnosis across Europe.
› Verified 4 days ago
Irving Chen, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 330 Bon Air Ctr, Greenbrae, CA 94904 Phone: 415-461-9093 | |
Gurinder Athwal, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 330 Bon Air Ctr, Greenbrae, CA 94904 Phone: 415-461-9093 | |
Eugene Malmquist, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 Bon Air Rd, Greenbrae, CA 94904 Phone: 415-925-7000 | |
Jonathan Schroer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 330 Bon Air Ctr, Greenbrae, CA 94904 Phone: 415-461-9363 | |
Diana Linh Chi Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 330 Bon Air Ctr, Greenbrae, CA 94904 Phone: 415-461-9093 | |
Nadzeya Khomich, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 330 Bon Air Ctr, Greenbrae, CA 94904 Phone: 415-461-9093 | |
Nnamdi Chinedum Ndudikwa, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 330 Bon Air Ctr, Greenbrae, CA 94904 Phone: 415-461-9093 |